Home›People›Charles Perou
CP

Charles Perou

Director at GeneCentric Therapeutics.

ExecutiveDirector
Updated Oct 27, 2026·Latest SEC filing Jun 20, 2025·Suggest an edit

About Charles Perou

Charles Perou is a director at GeneCentric Therapeutics.

Charles Perou first appears on SEC filings in 2013.

Experience

This experience comes from SEC filings. The years are when the filings name Charles Perou in the role, so the role may have started earlier or lasted longer.

GeneCentric Therapeutics, Inc.
Director
2013 – 2025 · Durham, NC

Key Colleagues at Startups

The people Charles Perou works with at each company, as listed on that company's latest Form D.

GeneCentric Therapeutics, Inc. · Form D, Jun 20, 2025
CT
Clay Thorp
Director
MM
Michael Milburn
Executive officer and director
AL
PR
DH
Don Hardison
Director

Sources

  1. SECGeneCentric Therapeutics, Inc. Form D, filed Jun 20, 2025